Clinical Trials in Boston

Showing 7101-7120 of 17,836 trials

Virtual Reality Intervention for Speech Anxiety

NCT06086756

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.

Public SpeakingSpeech Anxiety

Boston University Charles River Campus48 participantsStarted Nov 2023

Boston, Massachusetts, United States

COMPLETEDPhase 2< 1 mile

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

NCT03538301

A phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, biological activity, and pharmacokinetics (PK) of ND-L02-s0201 for Injection in subjects with IPF.

Idiopathic Pulmonary Fibrosis

Nitto Denko Corporation123 participantsStarted Jun 2018

Tucson, Arizona, United States • Los Angeles, California, United States • Northridge, California, United States +30 more locations

Virtual Reality Intervention for Speech Anxiety

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

Find Trials by Condition in Boston

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Approaches and Decisions for Acute Pediatric TBI Trial

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

Inhibitory Control: Effects of Modulation

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

Adaptive RadioTherapy for OroPharynx Cancer

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

Examine the Psychosocial Impacts of COVID-19 Pandemic.